Acceleration of Tissue Plasminogen Activator-Mediated Thrombolysis by Magnetically Powered Nanomotors

Dose control and effectiveness promotion of tissue plasminogen activator (t-PA) for thrombolysis are vitally important to alleviate serious side effects such as hemorrhage in stroke treatments. In order to increase the effectiveness and reduce the risk of stroke treatment, we use rotating magnetic n...

Full description

Saved in:
Bibliographic Details
Published in:ACS nano 2014-08, Vol.8 (8), p.7746-7754
Main Authors: Cheng, Rui, Huang, Weijie, Huang, Lijie, Yang, Bo, Mao, Leidong, Jin, Kunlin, ZhuGe, Qichuan, Zhao, Yiping
Format: Article
Language:English
Subjects:
Animals
Diffusion
Drug Delivery Systems - instrumentation
Fibrin - metabolism
Mice
Mice, Inbred C57BL
Nanotechnology - instrumentation
Nanotubes
Rotation
Stroke - drug therapy
Thrombosis - drug therapy
Thrombosis - metabolism
Time Factors
Tissue Plasminogen Activator - administration & dosage
Tissue Plasminogen Activator - metabolism
Tissue Plasminogen Activator - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Dose control and effectiveness promotion of tissue plasminogen activator (t-PA) for thrombolysis are vitally important to alleviate serious side effects such as hemorrhage in stroke treatments. In order to increase the effectiveness and reduce the risk of stroke treatment, we use rotating magnetic nanomotors to enhance the mass transport of t-PA molecules at the blood clot interface for local ischemic stroke therapy. The in vitro experiments demonstrate that, when combined with magnetically activated nanomotors, the thrombolysis speed of low-concentration t-PA (50 μg mL–1) can be enhanced up to 2-fold, to the maximum lysis speed at high t-PA concentration. Based on the convection enhanced transport theory due to rotating magnetic nanomotors, a theoretical model is proposed and predicts the experimental results reasonably well. The validity and efficiency of this enhanced treatment has been demonstrated in a rat embolic model.
ISSN:1936-0851
1936-086X
DOI:10.1021/nn5029955